406 related articles for article (PubMed ID: 32108379)
1. Tight junctions in the development of asthma, chronic rhinosinusitis, atopic dermatitis, eosinophilic esophagitis, and inflammatory bowel diseases.
Sugita K; Kabashima K
J Leukoc Biol; 2020 May; 107(5):749-762. PubMed ID: 32108379
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease.
Pothoven KL; Norton JE; Hulse KE; Suh LA; Carter RG; Rocci E; Harris KE; Shintani-Smith S; Conley DB; Chandra RK; Liu MC; Kato A; Gonsalves N; Grammer LC; Peters AT; Kern RC; Bryce PJ; Tan BK; Schleimer RP
J Allergy Clin Immunol; 2015 Sep; 136(3):737-746.e4. PubMed ID: 25840724
[TBL] [Abstract][Full Text] [Related]
3. Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4.
Soyka MB; Wawrzyniak P; Eiwegger T; Holzmann D; Treis A; Wanke K; Kast JI; Akdis CA
J Allergy Clin Immunol; 2012 Nov; 130(5):1087-1096.e10. PubMed ID: 22840853
[TBL] [Abstract][Full Text] [Related]
4. Relationship of skin barrier breakdown and eosinophilic esophagitis.
Simon D; Simon HU
J Allergy Clin Immunol; 2020 Jan; 145(1):90-92.e1. PubMed ID: 31738992
[No Abstract] [Full Text] [Related]
5. Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases.
Lee SH
Intest Res; 2015 Jan; 13(1):11-8. PubMed ID: 25691839
[TBL] [Abstract][Full Text] [Related]
6. Exploring the immunopathology of type 2 inflammatory airway diseases.
AlBloushi S; Al-Ahmad M
Front Immunol; 2024; 15():1285598. PubMed ID: 38680486
[TBL] [Abstract][Full Text] [Related]
7. Updated epithelial barrier dysfunction in chronic rhinosinusitis: Targeting pathophysiology and treatment response of tight junctions.
Huang ZQ; Liu J; Sun LY; Ong HH; Ye J; Xu Y; Wang DY
Allergy; 2024 May; 79(5):1146-1165. PubMed ID: 38372149
[TBL] [Abstract][Full Text] [Related]
8. Filaggrin and tight junction proteins are crucial for IL-13-mediated esophageal barrier dysfunction.
Wu L; Oshima T; Li M; Tomita T; Fukui H; Watari J; Miwa H
Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G341-G350. PubMed ID: 29746170
[TBL] [Abstract][Full Text] [Related]
9. Barrier dysfunction in the nasal allergy.
Fukuoka A; Yoshimoto T
Allergol Int; 2018 Jan; 67(1):18-23. PubMed ID: 29150353
[TBL] [Abstract][Full Text] [Related]
10. Yu-Ping-Feng-San ameliorates recurrent allergic inflammation of atopic dermatitis by repairing tight junction defects of the epithelial barrier.
Zheng J; Wang X; Tao Y; Wang Y; Yu X; Liu H; Ji L; Bao K; Wang C; Jia Z; Hong M
Phytomedicine; 2019 Feb; 54():214-223. PubMed ID: 30668371
[TBL] [Abstract][Full Text] [Related]
11. Epidermal tight junction barrier function is altered by skin inflammation, but not by filaggrin-deficient stratum corneum.
Yokouchi M; Kubo A; Kawasaki H; Yoshida K; Ishii K; Furuse M; Amagai M
J Dermatol Sci; 2015 Jan; 77(1):28-36. PubMed ID: 25511077
[TBL] [Abstract][Full Text] [Related]
12. Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis.
Yoshida K; Kubo A; Fujita H; Yokouchi M; Ishii K; Kawasaki H; Nomura T; Shimizu H; Kouyama K; Ebihara T; Nagao K; Amagai M
J Allergy Clin Immunol; 2014 Oct; 134(4):856-64. PubMed ID: 25282566
[TBL] [Abstract][Full Text] [Related]
13. Epithelial barrier dysfunctions in atopic dermatitis: a skin-gut-lung model linking microbiome alteration and immune dysregulation.
Zhu TH; Zhu TR; Tran KA; Sivamani RK; Shi VY
Br J Dermatol; 2018 Sep; 179(3):570-581. PubMed ID: 29761483
[TBL] [Abstract][Full Text] [Related]
14. Role of Superantigens in Allergic Inflammation: Their Relationship to Allergic Rhinitis, Chronic Rhinosinusitis, Asthma, and Atopic Dermatitis.
Muluk NB; Altın F; Cingi C
Am J Rhinol Allergy; 2018 Nov; 32(6):502-517. PubMed ID: 30253652
[TBL] [Abstract][Full Text] [Related]
15. Impact of Gastroesophageal Reflux Disease on Mucosal Immunity and Atopic Disorders.
Hait EJ; McDonald DR
Clin Rev Allergy Immunol; 2019 Oct; 57(2):213-225. PubMed ID: 30206783
[TBL] [Abstract][Full Text] [Related]
16. Tight junction defects in patients with atopic dermatitis.
De Benedetto A; Rafaels NM; McGirt LY; Ivanov AI; Georas SN; Cheadle C; Berger AE; Zhang K; Vidyasagar S; Yoshida T; Boguniewicz M; Hata T; Schneider LC; Hanifin JM; Gallo RL; Novak N; Weidinger S; Beaty TH; Leung DY; Barnes KC; Beck LA
J Allergy Clin Immunol; 2011 Mar; 127(3):773-86.e1-7. PubMed ID: 21163515
[TBL] [Abstract][Full Text] [Related]
17. Skin barrier in atopic dermatitis: beyond filaggrin.
Zaniboni MC; Samorano LP; Orfali RL; Aoki V
An Bras Dermatol; 2016; 91(4):472-8. PubMed ID: 27579743
[TBL] [Abstract][Full Text] [Related]
18. Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients.
Sugita K; Steer CA; Martinez-Gonzalez I; Altunbulakli C; Morita H; Castro-Giner F; Kubo T; Wawrzyniak P; Rückert B; Sudo K; Nakae S; Matsumoto K; O'Mahony L; Akdis M; Takei F; Akdis CA
J Allergy Clin Immunol; 2018 Jan; 141(1):300-310.e11. PubMed ID: 28392332
[TBL] [Abstract][Full Text] [Related]
19. Impaired Tight Junctions in Atopic Dermatitis Skin and in a Skin-Equivalent Model Treated with Interleukin-17.
Yuki T; Tobiishi M; Kusaka-Kikushima A; Ota Y; Tokura Y
PLoS One; 2016; 11(9):e0161759. PubMed ID: 27588419
[TBL] [Abstract][Full Text] [Related]
20. Epithelial physical barrier defects in chronic rhinosinusitis.
Jiao J; Wang C; Zhang L
Expert Rev Clin Immunol; 2019 Jun; 15(6):679-688. PubMed ID: 30925220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
